How Should Healthcare Providers Reposition Against Substitutes? A Competitive Positioning Map Approach
Direct answer: To reposition against substitutes, healthcare providers should map where they and their alternatives sit on the two dimensions patients and payers actually decide on — typically some version of "convenience/access" versus "clinical depth or trust" — then move deliberately toward an unclaimed, defensible position. The substitutes threatening most providers today aren't rival hospitals; they're telehealth platforms, retail clinics, urgent care chains, home-based care, and even "do nothing / self-treat." A Competitive Positioning Map forces you to name those substitutes honestly and find a space you can own.
Why substitutes, not competitors, are the real threat
Most healthcare strategy conversations still compare your system to the health system across town. That framing is comfortable and often obsolete. A primary care practice loses a routine visit not to another practice but to a $59 virtual urgent care visit or a pharmacy minute-clinic. A specialty group loses volume to home infusion, ambulatory surgery centers, and increasingly to AI symptom-checkers that reroute patients before they ever call.
Substitutes win on jobs to be done: speed, price transparency, and low friction. They usually lose on continuity, complex-case management, and trusted relationships. Repositioning is the act of deciding which of those jobs you will win decisively — and which you'll concede.
Building the Competitive Positioning Map, step by step
The Competitive Positioning Map is a two-axis chart plotting every option a patient or payer could choose, so you can see crowded and empty space. Here's how to build one that reflects healthcare reality rather than internal assumptions.
Step 1 — List every substitute, not just competitors. Include retail/urgent care, telehealth vendors, home care, ASCs, direct primary care, employer on-site clinics, and "self-care / delay." If you leave substitutes off the map, you'll optimize against the wrong threat.
Step 2 — Choose axes that reflect real decision criteria. Don't default to "quality vs. cost" — quality is table stakes and hard for patients to observe. Better axes are usually:
- Access / convenience (wait time, hours, digital front door, price clarity)
- Clinical depth & continuity (complexity handled, relationship, care coordination)
Payer-facing providers may swap one axis for total cost of care or outcome accountability.
Step 3 — Plot honestly using evidence, not ego. Position each option using data you can defend: appointment lead times, patient-reported access scores, referral leakage reports, payer network adequacy metrics, and Net Promoter or CAHPS results. If your leadership thinks you're high-access but your third-next-available appointment is three weeks out, plot the truth.
Step 4 — Find the white space and the traps. Look for: (a) empty quadrants where demand exists but no strong option sits; (b) the crowded corner where you're undifferentiated against cheaper substitutes; and (c) positions that only well-capitalized entrants can defend.
Step 5 — Define the move and the proof points. Repositioning is only real if it changes what you invest in. If you decide to own "complex, coordinated care with same-week access," the map should generate a punch list: same-week slots for high-acuity referrals, care navigators, and messaging that stops competing with a $59 telehealth visit you'll never beat on price.
What "good" looks like
A strong healthcare positioning map has three qualities. First, substitutes outnumber direct competitors on the chart — proof you looked outside your peer group. Second, each position is backed by a metric, not a slide-deck adjective. Third, the chosen position implies things you will stop doing. A provider that claims a differentiated position while still chasing every commodity visit hasn't repositioned; it's just added a tagline.
The output is board-ready when it answers: Where do we sit today? Where is the defensible white space? What three investments and two divestments move us there? What would tell us in six months that it's working?
Where Percision fits — and where a consultant or spreadsheet is enough
I work on content for Percision (a strategic intelligence platform), so treat this as one informed option rather than the only path.
Percision runs your business context through structured reasoning steps across specialist models to produce a positioning analysis, scenario comparisons, and a board-ready deck in minutes rather than weeks. For a provider organization, that's useful when you need to: pressure-test which substitutes actually threaten which service lines, model the financial impact of a repositioning move (volume shifts, payer mix, margin), and turn the map into an execution plan with KPI tracking. It's built as a co-pilot — your leadership stays in control of every judgment call, which matters in a field where clinical and regulatory nuance can't be automated away.
Broadly, research such as the 2023 BCG–Harvard field experiment found generative-AI tools raised consultants' output quality and speed on suitable analytical tasks — but the same study flagged degraded performance when tasks fell outside the model's reliable range. Positioning analysis is well inside the range; clinical strategy and compliance judgments are not. Use the tool for structure and speed, not for decisions that require your medical and legal expertise.
When you don't need Percision: If you're a single-site practice with three obvious substitutes and a clear-eyed medical director, a whiteboard and a spreadsheet will get you a usable map in an afternoon. If you're navigating a heavily regulated payer negotiation or a merger, hire a healthcare strategy consultant who lives in that terrain. The map is the same; the right tool scales with your complexity and stakes.
If you want to build a positioning map and a financial-impact model quickly, you can run your context through Percision and keep every strategic call in your leadership team's hands.
What this looks like when the analysis is actually run
The substitute for an independent group is a hospital system that employs the same physicians. Repositioning means owning something employment cannot transfer.
The subject is Cedar Ridge Health Partners, a sample company profile we use for testing rather than a customer: a physician-owned multi-specialty group, $196M net patient revenue, 128 physicians, 14 clinics.
Excerpt from a real Percision run · Cost Reduction & Efficiency (T7) · sample company profile
The reposition. Sell coordinated care bundles directly to self-insured employers using existing clinic density and ASC capacity — transparent, fixed prices 8–12% below current commercial payer rates, without payer intermediaries.
The asset behind it. The 212,000 attributed lives provide the population base for credible pricing; the ASC provides the surgical capacity that competitors cannot replicate inside the same catchment; the 14-clinic footprint delivers coordinated episodes across primary care, orthopaedics, gastroenterology, cardiology and ambulatory surgery.
The capability that makes the position defensible. A platform calculating total cost of care per attributed member at a 30-day lag, replacing a 90-day manual chart abstraction process, with variance against manual abstraction at 5% or better by Month 18. Each additional attributed life improves actuarial precision and raises the licensing price by 3–5%.
What the position earns. 6.0–9.0× on $2M — $12–18M of incremental annual margin at a 9–11% operating margin, against a group operating margin of 4.2%.
| Phase | Gate metric | Target | Deadline |
|---|---|---|---|
| Foundation (0-6 months) | Physician-owner vote and pricing model validated | ≥75% physician-owner approval and actuarial sign-off | Month 6 |
| Traction (6-18 months) | Number of signed employer contracts | ≥2 contracts covering ≥4,000 lives | Month 18 |
| Scale (18-36 months) | Total covered lives and operating margin on employer channel | ≥10,000 covered lives at ≥9% operating margin | Month 36 |
The reposition is from "a group of physicians" to "a network that can quote a fixed price for an episode". A hospital system can employ the physicians; it cannot easily replicate a 14-clinic footprint plus an ASC inside the same catchment and quote a bundled price 8–12% below its own payer contracts, because that would cannibalise the contracts it already holds.
The measurement capability is what makes the position survivable rather than merely clever. Quoting fixed prices without knowing cost per member is how independent groups lose money on the exact contracts they won on price.
Read a complete Percision report — every page, no email required.
FAQ
What axes should healthcare providers use on a positioning map? Start with access/convenience versus clinical depth and continuity, since those drive patient and referral choices. Swap in total cost of care or outcome accountability when the map is aimed at payers rather than patients.
How is repositioning against substitutes different from beating competitors? Competitors offer the same service; substitutes offer a different way to get the same job done — a telehealth visit, a retail clinic, or simply waiting. Repositioning means choosing the jobs you'll win on rather than matching substitutes feature-for-feature.
Can AI tools replace a strategy consultant for this work? No. AI platforms like Percision accelerate the analysis and produce board-ready outputs, but clinical, regulatory, and negotiation judgment stay with your team or a specialized consultant. Treat AI as a co-pilot, not an autopilot.